Search Results - "SHEWACH, Donna"

Refine Results
  1. 1

    Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development by Bester, Assaf C., Roniger, Maayan, Oren, Yifat S., Im, Michael M., Sarni, Dan, Chaoat, Malka, Bensimon, Aaron, Zamir, Gideon, Shewach, Donna S., Kerem, Batsheva

    Published in Cell (29-04-2011)
    “…Chromosomal instability in early cancer stages is caused by stress on DNA replication. The molecular basis for replication perturbation in this context is…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Antimetabolite Radiosensitizers by Shewach, Donna S, Lawrence, Theodore S

    Published in Journal of clinical oncology (10-09-2007)
    “…Radiosensitization with antimetabolites has improved clinical outcome for patients with solid malignancies, especially cancers of the GI tract, cervix, and…”
    Get full text
    Journal Article
  4. 4

    Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells by Mannava, Sudha, Grachtchouk, Vladimir, Wheeler, Linda J., Im, Michael, Zhuang, Dazhong, Slavina, Elena G., Mathews, Christopher K., Shewach, Donna S., Nikiforov, Mikhail A.

    Published in Cell cycle (Georgetown, Tex.) (01-08-2008)
    “…To identify C-MYC targets rate-limiting for proliferation of malignant melanoma, we stably inhibited C-MYC in several human metastatic melanoma lines via…”
    Get full text
    Journal Article
  5. 5
  6. 6

    N -acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers by Medina, Scott H, Tekumalla, Venkatesh, Chevliakov, Maxim V, Shewach, Donna S, Ensminger, William D, El-Sayed, Mohamed E.H

    Published in Biomaterials (01-06-2011)
    “…Abstract There is an urgent need for novel polymeric carriers that can selectively deliver a large dose of chemotherapeutic agents into hepatic cancer cells to…”
    Get full text
    Journal Article
  7. 7

    Detection of Nucleotide Disbalance in Cells Undergoing Oncogene-Induced Senescence by Nikiforov, Mikhail A, Shewach, Donna S

    “…DNA damage response has been characterized as an important mediator of senescence phenotypes induced by activated oncogenes in normal human cells. Depletion of…”
    Get more information
    Journal Article
  8. 8

    Folate levels modulate oncogene‐induced replication stress and tumorigenicity by Lamm, Noa, Maoz, Karin, Bester, Assaf C, Im, Michael M, Shewach, Donna S, Karni, Rotem, Kerem, Batsheva

    Published in EMBO molecular medicine (01-09-2015)
    “…Chromosomal instability in early cancer stages is caused by replication stress. One mechanism by which oncogene expression induces replication stress is to…”
    Get full text
    Journal Article
  9. 9

    Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine by Im, Michael M., Flanagan, Sheryl A., Ackroyd, Jeffrey J., Knapp, Brendan, Kramer, Aaron, Shewach, Donna S.

    Published in Radiation research (01-11-2016)
    “…Gemcitabine (dFdCyd) shows broad antitumor activity in solid tumors in chemotherapeutic regimens or when combined with ionizing radiation (radiosensitization)…”
    Get full text
    Journal Article
  10. 10

    Drug Metabolism and Homologous Recombination Repair in Radiosensitization with Gemcitabine by Im, Michael M., Flanagan, Sheryl A., Ackroyd, Jeffrey J., Shewach, Donna S.

    Published in Radiation research (01-01-2015)
    “…Gemcitabine (difluorodeoxycytidine; dFdCyd) is a potent radiosensitizer, noted for its ability to enhance cytotoxicity with radiation at noncytotoxic…”
    Get full text
    Journal Article
  11. 11

    Short Hairpin RNA Suppression of Thymidylate Synthase Produces DNA Mismatches and Results in Excellent Radiosensitization by Flanagan, Sheryl A., PhD, Cooper, Kristin S, Mannava, Sudha, MSc, Nikiforov, Mikhail A., PhD, Shewach, Donna S., PhD

    “…Purpose To determine the effect of short hairpin ribonucleic acid (shRNA)-mediated suppression of thymidylate synthase (TS) on cytotoxicity and…”
    Get full text
    Journal Article
  12. 12

    Laboratory and Clinical Evidence of Synergistic Cytotoxicity of Sequential Treament With Gemcitabine Followed by Docetaxel in the Treatment of Sarcoma by LEU, Kirsten M, OSTRUSZKA, Leo J, SHEWACH, Donna, ZALUPSKI, Mark, SONDAK, Vernon, BIERMANN, J. Sybil, SHIN-JUNG LEE, Julia, COUWLIER, Carol, PALAZZOLO, Krisinda, BAKER, Laurence H

    Published in Journal of clinical oncology (01-05-2004)
    “…Purpose A recent report of the combination of gemcitabine and docetaxel described favorable results in patients with uterine leiomyosarcoma. The objective of…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity by Ladd, Brendon, Ackroyd, Jeffrey J., Hicks, J. Kevin, Canman, Christine E., Flanagan, Sheryl A., Shewach, Donna S.

    Published in DNA repair (01-12-2013)
    “…•Homologous recombination deficiency enhances ganciclovir cytotoxicity >14-fold.•Vorinostat inhibits homologous recombination repair…”
    Get full text
    Journal Article
  14. 14

    A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy by BOUCHER, Paul D, IM, Michael M, FREYTAG, Svend O, SHEWACH, Donna S

    Published in Cancer research (Chicago, Ill.) (15-03-2006)
    “…The combination of cytosine deaminase (CD) and herpes simplex virus thymidine kinase (HSV-TK) suicide gene protocols has resulted in enhanced antitumor…”
    Get full text
    Journal Article
  15. 15

    Targeting Hepatic Cancer Cells with PEGylated Dendrimers Displaying N-Acetylgalactosamine and SP94 Peptide Ligands by Medina, Scott H., Tiruchinapally, Gopinath, Chevliakov, Maxim V., Durmaz, Yasemin Yuksel, Stender, Rachell N., Ensminger, William D., Shewach, Donna S., ElSayed, Mohamed E. H.

    Published in Advanced healthcare materials (01-10-2013)
    “…Poly(amidoamine) (PAMAM) dendrimers are branched water‐soluble polymers defined by consecutive generation numbers (Gn) indicating a parallel increase in size,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: a new paradigm for antimetabolite radiosensitizers by Flanagan, Sheryl A, Robinson, Blaine W, Krokosky, Christina M, Shewach, Donna S

    Published in Molecular cancer therapeutics (01-06-2007)
    “…Radiation sensitization by 2′,2′-difluoro-2′-deoxycytidine (dFdCyd) has correlated with dATP depletion [dFdCDP-mediated inhibition of ribonucleotide reductase…”
    Get full text
    Journal Article
  18. 18

    MLH1 deficiency enhances radiosensitization with 5-fluorodeoxyuridine by increasing DNA mismatches by Flanagan, Sheryl A, Krokosky, Christina M, Mannava, Sudha, Nikiforov, Mikhail A, Shewach, Donna S

    Published in Molecular pharmacology (01-09-2008)
    “…The antitumor drug 5-fluoro-2'-deoxyuridine (FdUrd) also sensitizes tumor cells to ionizing radiation in vitro and in vivo. Although radiosensitization with…”
    Get more information
    Journal Article
  19. 19

    Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells by ROBINSON, Blaine W, IM, Michael M, LJUNGMAN, Mats, PRAZ, Francoise, SHEWACH, Donna S

    Published in Cancer research (Chicago, Ill.) (15-10-2003)
    “…Gemcitabine [2',2'-difluoro-2'-deoxycytidine (dFdCyd)] is a potent ionizing radiation sensitizer in solid tumor cells in vitro and in vivo. Previously, we have…”
    Get full text
    Journal Article
  20. 20

    In vitro and in vivo enhancement of ganciclovir-mediated bystander cytotoxicity with gemcitabine by Boucher, Paul D, Shewach, Donna S

    Published in Molecular therapy (01-12-2005)
    “…To improve bystander cell killing with HSV-TK/GCV, we have utilized dFdCyd to reduce endogenous dGTP, which competes with GCVTP for incorporation into DNA. In…”
    Get full text
    Journal Article